BACKGROUND/AIM: Neonatal infection can sensitize the adult substantia nigra (SN) to secondary insults, causing a decrease in antioxidant capacity which may lead to Parkinson's disease in adults. We studied the prolonged effect of systemic infection by (i.p.) administration of lipopolysaccharide (LPS) on interleukin (IL)-1β, the antioxidant regulator nuclear factor-erythroid 2-related factor 2 (Nrf2), and the peroxisome proliferator-activated receptor γ coactivator (PGC)-1α in rat SN. METHOD AND RESULTS: Five-day-old rat pups were treated with LPS (i.p. 2 mg/kg). After 65 days, the mRNA level of IL-1β was significantly increased, in parallel with a decrease in that of the rate-limiting enzyme in glutathione synthesis, the γ-glutamylcysteine ligase catalytic subunit (γGCLc), Nrf2, and brain-derived neurotrophic factor (BDNF). Protein levels of γGCLc and Nrf2 were decreased while IL-1β protein was significantly increased. These LPS-induced long-term changes correlated with a decrease in phosphorylated (active) AKT (pAKT) and phosphorylated (inactive) GSK-3β (pGSK-3β). In another set of experiments, a 0.1% Spirulina-containing diet was given to lactating mothers 24 h before the LPS treatment of the pups. The Spirulina-supplemented diet decreased IL-1β protein expression in SN and elevated the mRNA level of γGCLc, Nrf2 protein, PGC-1α protein, and pAKT. CONCLUSION: Early-life infection can negatively affect Nrf2, pAKT, and pGSK-3β for a long time in SN. A diet enriched with antioxidant and anti-inflammatory phytochemicals can partly restore some, but not all, of the effects on the antioxidant defense, possibly via normalizing effects on pAKT.
BACKGROUND/AIM: Neonatal infection can sensitize the adult substantia nigra (SN) to secondary insults, causing a decrease in antioxidant capacity which may lead to Parkinson's disease in adults. We studied the prolonged effect of systemic infection by (i.p.) administration of lipopolysaccharide (LPS) on interleukin (IL)-1β, the antioxidant regulator nuclear factor-erythroid 2-related factor 2 (Nrf2), and the peroxisome proliferator-activated receptor γ coactivator (PGC)-1α in rat SN. METHOD AND RESULTS: Five-day-old rat pups were treated with LPS (i.p. 2 mg/kg). After 65 days, the mRNA level of IL-1β was significantly increased, in parallel with a decrease in that of the rate-limiting enzyme in glutathione synthesis, the γ-glutamylcysteine ligase catalytic subunit (γGCLc), Nrf2, and brain-derived neurotrophic factor (BDNF). Protein levels of γGCLc and Nrf2 were decreased while IL-1β protein was significantly increased. These LPS-induced long-term changes correlated with a decrease in phosphorylated (active) AKT (pAKT) and phosphorylated (inactive) GSK-3β (pGSK-3β). In another set of experiments, a 0.1% Spirulina-containing diet was given to lactating mothers 24 h before the LPS treatment of the pups. The Spirulina-supplemented diet decreased IL-1β protein expression in SN and elevated the mRNA level of γGCLc, Nrf2 protein, PGC-1α protein, and pAKT. CONCLUSION: Early-life infection can negatively affect Nrf2, pAKT, and pGSK-3β for a long time in SN. A diet enriched with antioxidant and anti-inflammatory phytochemicals can partly restore some, but not all, of the effects on the antioxidant defense, possibly via normalizing effects on pAKT.
Authors: Seo-Hyun Cho; Jason A Chen; Faten Sayed; Michael E Ward; Fuying Gao; Thi A Nguyen; Grietje Krabbe; Peter Dongmin Sohn; Iris Lo; Sakura Minami; Nino Devidze; Yungui Zhou; Giovanni Coppola; Li Gan Journal: J Neurosci Date: 2015-01-14 Impact factor: 6.167
Authors: Staci D Bilbo; Ruth M Barrientos; Andrea S Eads; Alexis Northcutt; Linda R Watkins; Jerry W Rudy; Steven F Maier Journal: Brain Behav Immun Date: 2007-11-07 Impact factor: 7.217
Authors: Ana I Rojo; Nadia G Innamorato; Ana M Martín-Moreno; María L De Ceballos; Masayuki Yamamoto; Antonio Cuadrado Journal: Glia Date: 2010-04 Impact factor: 7.452
Authors: Malin von Otter; Sara Landgren; Staffan Nilsson; Dragana Celojevic; Petra Bergström; Anna Håkansson; Hans Nissbrandt; Marek Drozdzik; Monika Bialecka; Mateusz Kurzawski; Kaj Blennow; Michael Nilsson; Ola Hammarsten; Henrik Zetterberg Journal: BMC Med Genet Date: 2010-03-02 Impact factor: 2.103
Authors: Malin von Otter; Sara Landgren; Staffan Nilsson; Madeleine Zetterberg; Dragana Celojevic; Petra Bergström; Lennart Minthon; Nenad Bogdanovic; Niels Andreasen; Deborah R Gustafson; Ingmar Skoog; Anders Wallin; Gunnar Tasa; Kaj Blennow; Michael Nilsson; Ola Hammarsten; Henrik Zetterberg Journal: Mech Ageing Dev Date: 2010-01-12 Impact factor: 5.432